| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9283209 | Microbes and Infection | 2005 | 6 Pages |
Abstract
The urgent need for a vaccine against HIV/AIDS requires that multiple strategies be employed and evaluated in a clinical setting. V2-loop deleted trimeric envelope (Env) immunogens (protein and DNA) from subtypes B and C human immunodeficiency virus type 1 (HIV-1) strains were produced for ongoing and future clinical evaluations with other HIV antigens, adjuvants and deliveries.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Susan W. Barnett, Indresh K. Srivastava, Jeffrey B. Ulmer, John J. Donnelly, Rino Rappuoli,